Official Release Repository: CDC

CDC HAN First Case of Clade I Mpox Diagnosed in the United States

CDC HAN – November 18, 2024

ACIP recommends MenB-4C (Bexsero®️) be administered as a 2-dose series at 0 and 6 months when given to healthy adolescents and young adults aged 16–23 years based on shared clinical decision-making. ACIP recommends MenB-4C (Bexsero®️) be administered as a 3-dose series at 0, 1–2, and 6 months when given to persons aged 10 years and older at increased risk for serogroup B meningococcal disease

CDC ACIP – October 24, 2024

CDC approves ACIP recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose

CDC Media Release – October 23, 2024

CDC approves ACIP recommendation for lowering the age for pneumococcal vaccination from 65 to 50 years old

CDC Media Release – October 23, 2024

CDC posts updated COVID-19 Vaccine Information Statement for everyone 6 months of age and older

CDC VIS – October 17, 2024

CDC posts updated RSV vaccine Vaccine Information Statement

CDC VIS – October 17, 2024

CDC posts updated Cholera Vaccine Information Statement

CDC VIS – October 17, 2024

CDC HAN Prevention Strategies for Mpox, including Vaccinating People at Risk via Sexual Exposure, for U.S. Travelers Visiting Countries with Clade I Mpox Outbreaks

CDC HAN – September 23, 2024

CDC HAN Health Update Mpox Caused by Human-to-Human Transmission of Monkeypox Virus in the Democratic Republic of the Congo with Spread to Neighboring Countries

CDC HAN – August 7, 2024

CDC approves ACIP recommendations for RSV for adults, DTaP-IPV-Hib-HepB (Vaxelis®️), COVID-19, Influenza, and Pneumococcal Vaccines

CDC ACIP – June 28, 2024

CDC Recommends Updated 2024-2025 COVID-19 and Flu Vaccines for Fall/Winter Virus Season

CDC Media Release – June 27, 2024

CDC updates addendum pages of the 2024 Child/Adolescent Recommended Immunization Schedule

CDC – June 27, 2024

CDC updates addendum pages of the 2024 Adult Recommended Schedule

CDC – June 27, 2024

CDC Updates RSV Vaccination Recommendation for Adults

CDC Media Release – June 26, 2024

CDC HAN Health Advisory "Increased Risk of Dengue Virus Infections in the United States"

CDC HAN – June 25, 2024

CDC HAN Health Advisory "Meningococcal Disease Cases Linked to Travel to the Kingdom of Saudi Arabia (KSA): Ensure Pilgrims are Current on Meningococcal Vaccination"

CDC HAN – May 20, 2024

CDC HAN Health Advisory "Highly Pathogenic Avian Influenza A(H5N1) Virus: Identification of Human Infection and Recommendations for Investigations and Response"

CDC HAN – April 5, 2024

CDC HAN Health Advisory Increase in Invasive Serogroup Y Meningococcal Disease in the United States

CDC HAN – March 28, 2024

CDC HAN Health Advisory Increase in Global and Domestic Measles Cases and Outbreaks: Ensure Children in the United States and Those Traveling Internationally 6 Months and Older are Current on MMR Vaccination

CDC HAN – March 18, 2024

CDC posts guidance for constrained U.S. Td supply, 2024

CDC – March 6, 2024

CDC updates and simplifies respiratory virus recommendations

CDC Media Release – March 1, 2024

CDC endorses ACIP recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose.

CDC Media Release – February 28, 2024

CDC endorses ACIP recommendations for additional dose 2023-24 COVID-19 vaccine for adults ages 65 years and older and Chikungunya vaccine for travelers and lab workers

CDC – February 28, 2024

CDC Urges Mpox Vaccination for Those Eligible Given Continued U.S. Mpox Cases

CDC COCA Now – February 12, 2024

Stay Alert for Measles Cases

CDC COCA Now – January 25, 2024

CDC’s guidance on using Td for infants and children who should not receive acellular pertussis-containing vaccines

CDC – January 23, 2024

Information on Respiratory Syncytial Virus (RSV) Vaccine Administration Errors in Young Children and Pregnant People

CDC COCA Now – January 22, 2024

CDC posts Updated Guidance for Healthcare Providers on Increased Supply of Nirsevimab to Protect Young Children from Severe Respiratory Syncytial Virus (RSV) during the 2023–2024

CDC COCA Now – January 5, 2024

CDC posts new Tick-Borne Encephalitis (TBE) vaccine Vaccine Information Statement

CDC VIS – December 7, 2023

CDC Guidelines for the Prevention and Treatment of Anthrax, 2023. The updated guidelines in this report can be used by health care providers to prevent and treat anthrax and guide emergency preparedness officials and planners as they develop and update plans for a wide-area aerosol release of B. anthracis.

CDC MMWR – November 17, 2023

2024 U.S. Recommended Immunization Schedule for Adults Aged 19 years or Older

CDC – November 16, 2023

2024 U.S. Recommended Immunization Schedule for Children and Adolescents Aged 18 years or Younger

CDC – November 16, 2023

CDC revises schedules, including addenda, for new or updated ACIP vaccine recommendations for children and adults

CDC – October 26, 2023

CDC revises schedules, including addenda, for new or updated ACIP vaccine recommendations for children and adults

CDC – October 26, 2023

CDC approves ACIP recommendations for meningococcal and mpox vaccines, approves the 2024 US Recommended Child and Adolescent Immunization Schedule and Recommended Adult Immunization Schedule

CDC ACIP – October 26, 2023

CDC posts updated RSV vaccine Vaccine Information Statement

CDC VIS – October 19, 2023

CDC posts new COVID-19 Vaccine Information Statement for mRNA vaccines for 12 years and older

CDC VIS – October 19, 2023

CDC posts RSV Preventive Antibody Immunization Information Statement

CDC – September 25, 2023

CDC recommends seasonal administration of one dose of RSV vaccine (Abrysvo, Pfizer) for pregnant people during weeks 32 through 36 of pregnancy to protect their newborn from severe RSV illness

CDC Media Release – September 22, 2023

CDC recommends everyone 6 months and older get an updated COVID-19 vaccine. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.

CDC Media Release – September 19, 2023

CDC recommends everyone 6 months and older get an updated COVID-19 vaccine. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.

CDC Media Release – September 12, 2023

CDC adopts ACIP recommendation for the use of nirsevimab (Beyfortus, Sanofi), a long-acting monoclonal antibody product shown to reduce the risk of both hospitalizations and healthcare visits for RSV in infants by about 80 percent

CDC Media Release – August 3, 2023

CDC posts updated Multiple Vaccines (“Your Child’s First Vaccines”) Vaccine Information Statement

CDC VIS – July 24, 2023

CDC posts new Respiratory Syncytial Virus (RSV) Vaccine Information Statement

CDC VIS – July 24, 2023

CDC adopts 2023-24 ACIP flu vaccination recommendations, to be published later this summer

CDC ACIP – June 29, 2023

CDC recommends RSV vaccine for older adults using shared clinical decision-making

CDC Media Release – June 29, 2023

Updated Hepatitis B Vaccine Information Statement (VIS) posted

CDC VIS – May 12, 2023

Updated Pneumococcal Conjugate Vaccine Information Statement (VIS) posted

CDC VIS – May 5, 2023

CDC simplifies COVID-19 vaccine recommendations, allows older adults and immunocompromised adults to get second dose of the bivalent vaccine. Monovalent (original) COVID-19 mRNA COVID-19 vaccines no longer recommended for use in the United States.

CDC Media Release – April 19, 2023

2023 U.S. Recommended Immunization Schedule for Adults Aged 19 Years or Older

CDC – February 10, 2023

2023 U.S. Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger

CDC – February 10, 2023

CDC expands updated COVID-19 vaccines to include children ages 6 months through 5 years

CDC Media Release – December 9, 2022

Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – November 14, 2022

CDC allows those 18 years and older option to receive a Novavax monovalent booster instead of an updated (bivalent) Pfizer-BioNTech or Moderna booster if they have completed primary series vaccination but have not previously received a COVID-19 booster.

CDC Media Release – October 19, 2022

CDC recommends expanding the use of updated (bivalent) COVID-19 vaccines (Pfizer-BioNTech for children ages 5 through 11 years, Moderna for children and adolescents ages 6 through 11 years) to children ages 5 through 11 years.

CDC Media Release – October 12, 2022

US joins list of 30 countries that meet WHO criteria for circulating vaccine-derived poliovirus (cVDPV)

CDC Media Release – September 13, 2022

CDC recommends the first updated COVID-19 booster (bivalent booster)

CDC Media Release – September 1, 2022

Updated Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – August 23, 2022

CDC recommends Novavax COVID-19 vaccine for use in adolescents 12 years through 17 years as a primary series option.

CDC Media Release – August 22, 2022

New Vaccine Information Statement (VIS) posted for Ebola vaccine

CDC VIS – June 30, 2022

CDC endorsed ACIP recommendation of Moderna’s COVID-19 vaccine for those 6 through 17 years of age, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older

CDC Media Release – June 24, 2022

CDC endorsed the ACIP recommendation that all children 6 months through 5 years of age should receive a Moderna or Pfizer-BioNTech COVID-19 vaccine. All children, including children who have already had COVID-19, should get vaccinated

CDC Media Release – June 18, 2022

Updated Vaccine Information Statement (VIS) for rabies vaccine released

CDC VIS – June 2, 2022

New Vaccine Information Statement (VIS) for smallpox/monkeypox vaccine (Jynneos) released

CDC VIS – June 1, 2022

CDC recommends that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series, strengthens its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first

CDC Media Release – May 19, 2022

Vaccine Topics

General Topics

Patient Safety Honor Rolls

Our Affiliated Sites